Physician profile
Peter H Segall
NPI 1326079864
$377.10
in general payments reported to CMS, 2019-2025
11 companies · $41.74 in 2025
The $41.74 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119 · 2020: $41.91 · 2022: $20.46 · 2023: $43.61 · 2024: $110 · 2025: $41.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $195.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $101.35 | 2019-2023 | Camzyos |
| Amgen INC. | $72.81 | 2019-2020 | |
| Exact Sciences Corporation | $40.72 | 2023-2024 | Cologuard Collection Kit |
| Lilly USA, LLC | $36.43 | 2024 | Mounjaro, Zepbound |
| Baxter Healthcare | $22.36 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Heartflow, INC. | $19.38 | 2025 | |
| Sanofi-Aventis U.S. LLC | $18.91 | 2019 | |
| Pfizer INC. | $18.05 | 2024 | |
| Janssen Pharmaceuticals, INC | $17.78 | 2024 | Xarelto |
| Irhythm Technologies, INC. | $17.69 | 2024 | Zio Xt Patch, Zio Monitor |
| Kowa Pharmaceuticals America, INC. | $11.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Segall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.